Roughly one in ten Americans suffers from major depressive disorder (MDD) at any given time. In total, up to 20 percent of ...

Peter Moulding joined a clinical trial for the drug AMP945 not really knowing whether it would help him with deadly stage ...

Many people still believe that building muscle means living at the gym and constantly training. Fresh evidence shows it's ...

A compound best known for giving almonds and apricots their aroma may be the key to defeating hard-to-kill cancer cells. Japanese researchers found that benzaldehyde can stop the shape-shifting ...

Researchers identified a unique protein signature in the blood of BMD and LGMD patients that may reflect disease progression.

Cancer cells have the capacity to multiply rapidly. The aggressive cancer cells undergo conversion from their tightly ...

Ensem Therapeutics doses first patient in phase 1/2 study of ETX-636, a novel allosteric pan-mutant-selective PI3Ka inhibitor and degrader: Waltham, Massachusetts Thursday, July 3 ...

DelveInsight’s Metastatic Prostate Cancer Pipeline report depicts a robust space with 80+ active players working to develop ...

Andre Hoelz, the Mary and Charles Ferkel Professor of Chemistry and Biochemistry and a Howard Hughes Medical Institute investigator, learned ...